• Issue

    Clinical & Experimental Ophthalmology: Volume 52, Issue 9

    901-1030
    December 2024
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION

Free Access

Issue Information

  • Pages: 901-904
  • First Published: 05 December 2024

EDITORIAL

Shifting paradigms in retinopathy of prematurity treatment: The promise and challenges of biosimilars

Robert H. Henderson MD(Res), FRCOphth,  Omar Warda MD, MRCS, 
  • Pages: 905-907
  • First Published: 05 December 2024

AI: From productivity dividend to better patient outcome

Michael Goggin FRANZCO, MS, 
  • Pages: 908-909
  • First Published: 05 December 2024

ORIGINAL ARTICLE-CLINICAL SCIENCE

Anisometropia and its correction in children in northwest China: A study based on autorefraction data

Qian Yao MS,  Junhan Wei MS,  Lu Ye MS,  Xianyi Duan MS,  Meixia Ren MS,  Jie Min MS,  Pei Cheng MS,  Guoyun Zhang MD, 
  • Pages: 910-919
  • First Published: 06 August 2024

Establishment of a new vault prediction formula after implantable collamer lens implantation based on factor analysis of multi-modal ophthalmic parameters of anterior and posterior chamber

Yijia Xu MD,  Fang Liu MD,  Yuhao Ye MD,  Zhe Zhang MD,  Lingling Niu MD,  Peijun Yao MD,  Xiaoying Wang MD,  Xingtao Zhou MD, PHD,  Jing Zhao MD, 
  • Pages: 920-933
  • First Published: 09 August 2024

Pain perception, aqueous humour cytokines, and miosis response following first and second eye femtosecond laser-assisted cataract surgery: A randomised, prospective, intraindividual study

Yinhui Yu MD,  Lixia Wang BS,  Yue Qiao PhD,  Yang Ye MD,  Yueyang Zhong MD,  Xiaohui Song MD,  Ke Yao MD,  Yibo Yu MD, PhD, 
  • Pages: 934-944
  • First Published: 12 August 2024

Investigating the uncertain causal link between gut microbiota and glaucoma: A genetic correlation and Mendelian randomisation study

Jiayong Li MD,  Xin Ma MD,  Kaichen Zhuo MD,  Yuxian He MD,  Mingkai Lin MD, PhD,  Wei Wang MD, PhD,  Shicheng Guo PhD,  Chao Tang PhD,  Xu Zhang MD,  Xinbo Gao MD, PhD, 
  • Pages: 945-956
  • First Published: 26 September 2024
Open Access

Healthcare professionals' knowledge and attitudes towards polygenic risk testing for glaucoma

Georgina L. Hollitt MBBS,  Miriam C. Keane PhD,  Thi T. Nguyen MOptom,  Mark M. Hassall MBBS, DPhil,  Owen M. Siggs MD, DPhil,  Jamie E. Craig DPhil, FRANZCO,  Emmanuelle Souzeau PhD, 
  • Pages: 957-972
  • First Published: 08 September 2024
Open Access

Nocturnal hypoxia and age-related macular degeneration

Attiqa Chaudhary MBBS,  Carla J. Abbott PhD,  Zhichao Wu PhD,  Wendy Y. Fang BMedSc(Hons), MD,  Palaniraj R. Raj MBBS, MMed(OphthSc),  Matthew Naughton MBBS, MD,  Wilson J. Heriot MBBS,  Robyn H. Guymer MBBS, PhD, 
  • Pages: 973-980
  • First Published: 01 August 2024
Open Access

Elevated aqueous TNF-α levels are associated with more severe functional and anatomic findings in eyes with diabetic macular oedema

Sky Chew FRANZCO,  Tuan Tran FRANZCO,  Paul Sanfilippo PhD,  Lyndell L. Lim PhD,  Sukhpal S. Sandhu FRANZCO,  Sanjeewa Wickremasinghe FRANZCO, 
  • Pages: 981-990
  • First Published: 28 July 2024

Assessment of prognostic factors in patients with primary ocular adnexal lymphoma when considering competing risk elements

Jing Zeng MD,  Xian-Fen Cao MD,  Jian Chen MD, PhD,  Zhi-ping Liu MD, PhD,  Jun Lyu PhD,  Qing Zhou MD, PhD, 
  • Pages: 991-1002
  • First Published: 01 August 2024

REVIEW

Open Access

Mimickers of hydroxychloroquine retinal toxicity

Peter Jones MD,  Gagan Kalra MD,  Mayss Al-Sheikh MD,  Jay Chhablani MD, 
  • Pages: 1003-1015
  • First Published: 03 December 2024

LETTER TO THE EDITOR

Evaluation of ChatGPT-4 responses to glaucoma patients' questions: Can artificial intelligence become a trusted advisor between doctor and patient?

Muzaffer Said Güler MD,  Elif Ertan Baydemir MD, 
  • Pages: 1016-1019
  • First Published: 15 October 2024

Epidemiology and visual outcomes of ocular trauma in the northernmost regions of the Northern Territory

Nicholas George Giannopoulos MD,  Danny Lam MMed,  Madelaine Moore MOrtho,  Hema Karthik FRANZCO, 
  • Pages: 1019-1023
  • First Published: 13 August 2024

Bevacizumab biosimilar (bevacizumab-awwb) is safe in the treatment of retinopathy of prematurity

Cindy Yue-Ying Liu MD,  Zixin Hong MD,  Shuan Dai FRANZCO,  Shivanand Sheth FRANZCO,  Shaheen Shah FRANZCO, 
  • Pages: 1023-1024
  • First Published: 09 September 2024

Comparison of intraocular pressure and anterior segment parameters in subjects with asymmetrical primary angle closure disease: Comment

Liang Guo MD,  Na Wang MD,  Lu Yang MD, 
  • Pages: 1025-1026
  • First Published: 17 October 2024

Comparison of intraocular pressure and anterior segment parameters in subjects with asymmetrical primary angle closure disease: Response

Shayne S. Tan MBBS, MRCS(Ed),  Tin A. Tun MBBS, PhD,  Monisha E. Nongpiur MD, PhD, 
  • Pages: 1026-1027
  • First Published: 15 October 2024

CONTINUING PROFESSIONAL DEVELOPMENT

Continuing Professional Development

  • Pages: 1028-1030
  • First Published: 05 December 2024